Ying Wang

ORCID: 0000-0002-4568-4026
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Clostridium difficile and Clostridium perfringens research
  • Gut microbiota and health
  • Gastrointestinal motility and disorders
  • Bacterial Identification and Susceptibility Testing
  • Streptococcal Infections and Treatments
  • Viral gastroenteritis research and epidemiology
  • Helicobacter pylori-related gastroenterology studies
  • Microscopic Colitis
  • Antimicrobial Resistance in Staphylococcus
  • Nosocomial Infections in ICU
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Clinical Nutrition and Gastroenterology
  • Diagnosis and treatment of tuberculosis
  • Botulinum Toxin and Related Neurological Disorders

Shandong Agricultural University
2023-2024

Jilin University
2023

Rutgers, The State University of New Jersey
2022

Robert Wood Johnson University Hospital
2022

Shenzhen Institutes of Advanced Technology
2021

Chinese Academy of Sciences
2021

Columbia University Irving Medical Center
2018-2019

Shanghai Institute of Nutrition and Health
2017

Dalian Medical University
2015

Second Affiliated Hospital of Jilin University
2015

Fecal microbiota transplantation (FMT) is a promising therapy, despite some reports of adverse side effects. Bacterial consortia (BCT) for targeted restoration the intestinal ecosystem considered relatively safe and simple procedure. However, no systematic research has assessed effects FMT BCT on immune responses mucosal barrier in patients. We conducted complementary studies animal models BCT, provide recommendations improving clinical outcomes these treatments. To establish dysbiosis...

10.3389/fmicb.2015.00692 article EN cc-by Frontiers in Microbiology 2015-07-07

Abstract Background Guidelines recommend adding intravenous (IV) metronidazole to oral vancomycin for fulminant Clostridioides difficile infection (CDI). In this study, we compared dual therapy with IV and vs monotherapy. We assessed prevalence of use effectiveness in nonfulminant CDI. Methods This was a 2-center retrospective study conducted from 2010 2018. Adult inpatients were included if they had positive C. polymerase chain reaction (PCR) performed on an unformed stool received within 2...

10.1093/cid/ciz1115 article EN Clinical Infectious Diseases 2019-11-09

Abstract Background Clostridium perfringens (Cp) is a Gram-positive anaerobic bacterium that causes necrotic enteritis (NE) in poultry when it overgrows the small intestine. NE disease has previously been controlled through use of growth-promoting antibiotics. This practice was recently banned European countries, leading to significantly increased incidence threatening industry. Control strategies and technology as substitutes dietary antibiotics are therefore urgently required. To develop...

10.1186/1471-2164-10-260 article EN cc-by BMC Genomics 2009-06-07

Clostridium perfringens is a zoonotic opportunistic pathogen that produces toxins can cause necrotic enteritis and even "sudden death disease". This bacterium widely distributed in the intestines of livestock human, but there are few reports distribution aquatic animals (Hafeez et al., 2022). In order to explore isolation rate C. toxin genes they carry, 141 samples, including clams (Clam), oysters (Ostreidae), mud snails (Bullacta exerata Philippi), were collected from coastal areas Shandong...

10.1016/j.ijfoodmicro.2024.110642 article EN cc-by-nc-nd International Journal of Food Microbiology 2024-02-28

Clostridium perfringens is a zoonotic conditional pathogen, producing toxins that can cause necrotic enteritis and even "sudden death disease". This bacterium widely distributed in the intestines of livestock human animals, but there are few reports distribution aquatic animals. In order to explore isolation rate C. its carrying toxin genes, 141 samples, including clams, oysters, mud snails, were collected from coastal areas Shandong Province, China. Cp. strains tested for cpa, cpb, etx,...

10.2139/ssrn.4635225 preprint EN 2023-01-01

Introduction:Clostridium difficile infection (CDI) is the leading cause of healthcare-associated diarrhea and gastroenteritis-associated death. Secondary bile acids inhibit C. germination in vitro confer resistance to CDI animals. Cholecystectomy (CCY) alters gut acid composition, with increased fecal levels secondary acids. This study tested hypothesis that remote CCY confers protection against by increasing Methods: was a retrospective case control study. The population included all adult...

10.14309/00000434-201810001-00168 article EN The American Journal of Gastroenterology 2018-10-01

Background and AimsClostridioides difficile infection (CDI) is associated with a range of outcomes, existing prediction models for death among patients CDI are imprecise. Peripheral eosinopenia has been proposed as novel risk factor but not incorporated into models. This study aimed to develop validate model hospitalized that peripheral eosinopenia.MethodsEosinopenia was defined 0 eosinophils/μL on the soonest blood drawn within 48-hour window test (before or after). Adults were eligible if...

10.1016/j.gastha.2021.10.002 article EN cc-by-nc-nd Gastro Hep Advances 2022-01-01

Abstract Fecal microbiota transplantation (FMT), a procedure in which fecal material is transferred from donor to recipient, has been increasingly used as treatment restore healthy gut microbiota. There substantial difference the composition of between young and aged hosts, but little known about whether age matching FMT recipient affects restoration long-term maintenance. In present investigation, we aimed study establishment resilience transplanted recipients. We treated naturally mice (20...

10.1101/2021.03.18.435923 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-03-18
Coming Soon ...